Use of Oral Probiotics to Reduce Urinary Oxalate Excretion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
NephrolithiasisHyperoxaluriaCrohn's Disease
Interventions
DIETARY_SUPPLEMENT

Oxadrop

Oxadrop 1 packet daily plus 1 placebo capsule twice daily. Each gram of Oxadrop® contains 2x1011 bacteria (L. acidophilus, L. brevis, S. thermophilus, and B. infantis).

DIETARY_SUPPLEMENT

Agri-King Synbiotic (AKSB)

AKSB 1 capsule twice daily plus 1 placebo packet daily. AKSB contains Fructo-oligosaccharide; Enterococcus faecium (SF68); Saccharomyces cerevisiae subspecies Boulardi; and Saccharomyces cerevisiae

OTHER

Placebo

1 placebo packet daily and 1 placebo capsule twice daily

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER